essence semaglutide In an interim analysis of a phase 3 trial involving 800 patients with metabolic dysfunction–associated steatohepatitis, once-weekly improved liver histologic results at 72 weeks. Full trial results and Research Summary Phase 3 ESSENCE trial: Semaglutide

A small subset of patients (approximately 47% in clinical trials) discontinue semaglutide due to intolerable gastrointestinal side effects that do not adequately resolve

Limited exceptions exist only for patients with documented medical needs that cannot be met by FDA-approved products, such as allergies to specific inactive ingredients

While this medication has been making waves in the news and social media, many people are still unclear about this drug

When injecting semaglutide, it is recommended that patients change the location they inject each time to avoid skin issues

The people who maintain their results are the ones who built lasting dietary habits during treatment rather than treating semaglutide as a temporary fix

Step 1: Wipe the rubber stopper of both the bacteriostatic water vial and the semaglutide vial with separate alcohol swabs